Understanding MAT access in the context of unused MAT capacity in the United States: when increasing rural MAT capacity is not enough

Table 3 Pharmacy and pharmacist barriers limiting MAT availability (N = 61)

Reasons	Number (%) of consortia endorsing reason (N = 61^a)
Business-Related Reasons
Concerns About Triggering a DEA Investigation	11 (18%)
Perceived Lack of Demand (causing concern the pharmacy would be left with unsold expired medications)	16 (26%)
Financial Losses Due to Medication Costs	9 (15%)
Pharmacist-Specific Reasons
Lack of MAT Knowledge or Training Among Pharmacists	15 (25%)
Not Wanting Individuals with OUD in the Pharmacy	10 (16%)
Reluctance to Dispense to Patients Not from the Area the Pharmacy Serves	9 (15%)
MAT Not Seen as Best Practice by Dispensing Pharmacists	8 (13%)

^a Questions on pharmacists and pharmacy barriers were only asked of consortia that reported that at least one medication for OUD had limited or no availability in their area. Among the 80 consortia included in our main analysis sample, 61 reported some limitations in medication availability and were included in this analysis

ISSN: 1747-597X